Trajectories of Cognition in Middle Age: Implications for Alzheimer's Disease and Related Dementias in the U.S.
中年认知轨迹:对美国阿尔茨海默病和相关痴呆症的影响
基本信息
- 批准号:10301111
- 负责人:
- 金额:$ 47.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAgeAge of OnsetAgingAlcohol consumptionAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAmericanChronicCognitionCognitiveCoupledCrimeDataData AnalysesData SetDementiaDiseaseElderlyEngineeringEnrollmentEnvironmentEnvironmental ExposureEnvironmental Risk FactorEpidemiologyExposure toFundingGeneticGenetic RiskHealthHealth StatusHealth and Retirement StudyHealth behaviorHealth behavior changeHypertensionImpaired cognitionIncidenceIndividualInterceptInterventionKnowledgeLife Cycle StagesLinkLongitudinal StudiesMeasuresMedicalNeighborhoodsObesityOutcomeParticipantPhysical environmentPlayPoliciesPollutionPopulationPredictive FactorPrevalencePreventionPrevention strategyPublic HealthRiskRisk FactorsRoleSocial EnvironmentSocial supportStudy modelsSubgroupSurveysTestingTimeUnited States National Academy of Sciencesage groupbasecognitive impairment no dementiadementia riskethnic minority populationfood insecuritygenetic risk factorhigh riskimprovedinterestlow socioeconomic statusmiddle agemodifiable risknovelprematurepreventracial and ethnictrend
项目摘要
PROJECT SUMMARY/ABSTRACT
The number of Americans with Alzheimer's disease and related dementias (ADRD) is projected to reach 13.8
million by 2050. Given the current lack of disease-modifying treatments for ADRD coupled with evidence that
ADRD develops over decades, there is growing interest in developing prevention strategies. Middle age (i.e.,
45-64 years) is increasingly recognized as a key life course period to target modifiable risk factors for cognitive
decline and ADRD. Prior studies have identified individual-level risk factors in middle age, including chronic
conditions such as hypertension and obesity and health-related behaviors such as excessive alcohol use. The
2020 Lancet Commission estimated that addressing these mid-life risk factors could result in up to 15% of
dementias being prevented or delayed. However, recent data suggests the need to look beyond individual-
level factors to examine the potential role of environmental exposures to improve health outcomes in mid-life
and reduce overall dementia burden. Since 1990, the prevalence of chronic conditions that are risk factors for
ADRD has increased in middle-aged adults, particularly in individuals with lower socioeconomic status (SES).
The reasons for these trends are not yet fully understood, but a leading hypothesis is that lower SES in middle
age is leading to premature onset of aging-related conditions through exposures in the social and physical
environment (e.g., levels of social support, crime, food insecurity, pollution). A growing number of studies have
linked such environmental factors to risk of cognitive decline and ADRD in older adults, and these factors could
also be impacting cognitive trajectories and risk of ADRD in middle age. However, key knowledge gaps
remain. First, it is unknown if cognitive outcomes are worsening in middle-aged adults, nor if environmental
exposures increase the risk of cognitive decline in middle age. Additionally, whereas cognitive decline and
ADRD in older adults result from the interplay of environmental and genetic risk factors, it is unclear how
genetic risk contributes to cognitive decline in middle age. A longitudinal study of middle-aged adults that
includes measures of environmental exposures and genetic data is needed to address these questions. The
objective of the proposed project is to examine if cognitive outcomes are worsening in middle age and how
environmental and genetic risk factors contribute to cognitive decline in this age group. The specific aims are
to: (1) examine the epidemiology of cognitive impairment in middle-aged adults in the U.S., including identifying
cognitive trajectories and incidence of “cognitive impairment no dementia” (CIND) over time; (2) determine if
environmental and genetic factors predict cognitive trajectories and incident CIND; and (3) replicate our
analyses in a second dataset. We will complete these aims using longitudinal nationally representative data
from the NIA-funded Health and Retirement Study. Findings will help elucidate the burden and mechanisms of
cognitive decline in middle age and inform policy planning to mitigate the projected burden of dementia.
项目摘要/摘要
患有阿尔茨海默氏病和相关痴呆症(ADRD)的美国人人数预计将达到13.8
到2050年,百万到2050年。鉴于目前缺乏疾病修改治疗ADRD的治疗方法以及证据表明
ADRD发展了数十年,人们对制定预防策略的兴趣越来越大。中年(即
45 - 64年)越来越被认为是关键的生活课程,以针对认知的可改变风险因素。
衰落和adrd。先前的研究已经确定了中年的个人级别危险因素,包括慢性
高血压和肥胖症以及与健康相关的行为(例如过量饮酒)等疾病。
2020年柳叶刀委员会估计,解决这些中期危险因素可能会导致多达15%
痴呆症被阻止或延迟。但是,最近的数据表明需要超越个体 -
级别因素,以检查环境暴露的潜在作用,以改善中年的健康状况
并减轻整体痴呆症负担。自1990年以来,慢性病的患病率是危险因素
在中年成年人中,ADRD有所增加,特别是在社会经济地位较低(SES)的个体中。
这些趋势的原因尚未完全理解,但是一个主要的假设是中间的SES较低
年龄通过在社会和身体上的暴露导致与衰老相关的状况过早发作
环境(例如,社会支持水平,犯罪,粮食不安全,污染)。越来越多的研究拥有
将这种环境因素与老年人认知下降和ADRD的风险联系起来,这些因素可能
还会影响中年的认知轨迹和ADRD的风险。但是,关键知识差距
保持。首先,尚不清楚认知结果是否在中年成年人中感到遗憾,也不知道环境
暴露会增加中年认知能力下降的风险。此外,认知能力下降和
老年人的ADRD是由于环境和遗传危险因素的相互作用而导致的,目前尚不清楚如何如何
遗传风险有助于中年认知下降。一项对中年成年人的纵向研究
包括环境暴露的措施和遗传数据以解决这些问题。
拟议项目的目的是检查认知结果是否在中年后悔
环境和遗传危险因素导致该年龄段的认知下降。具体目的是
至:(1)研究美国中年成年人认知障碍的流行病学,包括确定
随着时间的流逝,认知轨迹和“认知障碍无痴呆症”(CIND)的发生率; (2)确定是否
环境和遗传因素可以预测认知轨迹和事件cind; (3)复制我们的
在第二个数据集中进行分析。我们将使用纵向全国代表性数据来完成这些目标
来自NIA资助的健康和退休研究。调查结果将有助于阐明燃烧和机制
中年的认知能力下降并为政策计划提供信息,以减轻痴呆症的预计燃烧。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rebecca Tyler Brown其他文献
Rebecca Tyler Brown的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rebecca Tyler Brown', 18)}}的其他基金
Trajectories of Cognition in Middle Age: Implications for Alzheimer's Disease and Related Dementias in the U.S.
中年认知轨迹:对美国阿尔茨海默病和相关痴呆症的影响
- 批准号:
10618935 - 财政年份:2021
- 资助金额:
$ 47.75万 - 项目类别:
Trajectories of Cognition in Middle Age: Implications for Alzheimer's Disease and Related Dementias in the U.S.
中年认知轨迹:对美国阿尔茨海默病和相关痴呆症的影响
- 批准号:
10459606 - 财政年份:2021
- 资助金额:
$ 47.75万 - 项目类别:
Improving aging in place for older adults living in subsidized housing
改善居住在补贴住房中的老年人的就地老龄化
- 批准号:
9901413 - 财政年份:2018
- 资助金额:
$ 47.75万 - 项目类别:
Epidemiology and Outcomes of Premature Geriatrics Syndromes
早产儿老年综合症的流行病学和结果
- 批准号:
8843322 - 财政年份:2014
- 资助金额:
$ 47.75万 - 项目类别:
Epidemiology and Outcomes of Premature Geriatrics Syndromes
早产儿老年综合症的流行病学和结果
- 批准号:
8699566 - 财政年份:2014
- 资助金额:
$ 47.75万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The neural underpinnings of speech and nonspeech auditory processing in autism: Implications for language
自闭症患者言语和非言语听觉处理的神经基础:对语言的影响
- 批准号:
10827051 - 财政年份:2024
- 资助金额:
$ 47.75万 - 项目类别:
Computational and neural signatures of interoceptive learning in anorexia nervosa
神经性厌食症内感受学习的计算和神经特征
- 批准号:
10824044 - 财政年份:2024
- 资助金额:
$ 47.75万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 47.75万 - 项目类别:
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
- 批准号:
10748859 - 财政年份:2024
- 资助金额:
$ 47.75万 - 项目类别: